*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
STERCULIA QUADRIFIDA R.BR ETHYL ACETATE FRACTION INCREASES CISPLATIN CYTOTOXICITY ON T47D BREAST CANCER CELLS

Author: ROLLANDO ROLLANDO, KESTRILIA REGA PRILIANTI
Abstract: Cisplatin is a chemotherapeutic agent used as cancer cure with side effects and resistance. Ethyl acetate fraction of faloak bark (EAFB) are proven to have cytotoxic effect to cancer cells. This research aims to review the combination effect of cisplatin and EAFB to the sensitivity increase on breast cancer cells, which will be confirmed through apoptosis induction and cell cycle modulation. The cytotoxic effect was tested using MTT assay on T47D cell by using IC50 parameter. The combination was tested by determining their combination index (CI) and cell viability. The combination effect in apoptosis induction and cell cycle modulation were observed using flow cytometry method. The cytotoxic test result of the combination shows CI value of below 1 at the concentration of EAFB as much as 6 µg/mL, and cisplatin as much as 2,5 µM. The combination of EAFB and cisplatin results in phase S cell accumulation (29,98%) on breast cancer cell T47D and was able to induct apoptosis. It is proven that ethyl acetate fraction of faloak bark can be developed as a co-chemotherapeutic agent with cisplatin to increase the effectivity of breast cancer treatment
Keyword: Cisplatin, EAFB, cytoxicity, cell cycle, apoptosis
DOI: https://doi.org/10.31838/ijpr/2018.10.03.072
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free